Barzolvolimab, CAS 2438203-51-9

Product Description: Barzolvolimab (CDX 0159) is a humanized anti-KIT IgG1 monoclonal antibody. Barzolvolimab specificity and potently inhibits KIT activation by SCF. Barzolvolimab can reduce skin mast cells and disease activity in chronic inducible urticaria[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Terhorst-Molawi D, et, al. Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria. Allergy. 2022 Nov 16.

CAS Number: 2438203-51-9

Molecular Weight: N/A

Compound Purity: 99.83

Research Area: Inflammation/Immunology

Solubility: H2O

Target: c-Kit

• SKU: MEXHY-P99462-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99462-1
• Package Unit: 1 mg
• Quantity Unit: STK
• Conjugate: Unconjugated